MINERVA CARDIOLOGY AND ANGIOLOGY

Most read articles over the last three weeks

Minerva Cardioangiologica 2018 August;66(4):464-70
Cardiac rehabilitation after STEMI
Stefano URBINATI *, Elisabetta TONET

Minerva Cardioangiologica 2019 June;67(3):214-22
Antihypertensive effect of sacubitril/valsartan: a meta-analysis
Renato DE VECCHIS *, Carmelina ARIANO, Silvia SORECA

Minerva Cardiology and Angiology 2022 April;70(2):189-206
Prognostic implications of different clinical profiles in hypertrophic cardiomyopathy
Domitilla RUSSO, Matteo SCLAFANI, Giacomo TINI, M. Beatrice MUSUMECI, Luca ARCARI, Luca R. LIMITE, Pietro FRANCIA, Camillo AUTORE *

Minerva Cardiology and Angiology 2021 June;69(3):231-40
Cardiovascular disease burden: Italian and global perspectives
Andrea SAGLIETTO *, Roberto MANFREDI, Edoardo ELIA, Fabrizio D’ASCENZO, Gaetano M. DE FERRARI, Giuseppe BIONDI-ZOCCAI, Thomas MUNZEL

Minerva Cardiology and Angiology 2022 April;70(2):238-47
The inflammasome as a therapeutic target for myopericardial diseases
Massimo IMAZIO *, Antonio ABBATE

Minerva Cardiology and Angiology 2022 June;70(3):341-3
Diabetes and heart failure: from disease mechanisms to personalized care
Francesco DE SENSI, Francesco PANENI *

Minerva Cardioangiologica 2018 June;66(3):314-28
Transcatheter aortic valve implantation (TAVI) in 2018: recent advances and future development
Florian HECKER, Mani ARSALAN, Won-Keun KIM, Thomas WALTHER *

Minerva Cardiology and Angiology 2021 October;69(5):596-605
Early versus late tracheal intubation in COVID-19 patients: a “pros/cons” debate also considering heart-lung interactions
Luca CABRINI, Luca GHISLANZONI, Paolo SEVERGNINI, Giovanni LANDONI *, Martina BAIARDO REDAELLI, Federico FRANCHI, Stefano ROMAGNOLI

Minerva Cardiology and Angiology 2022 June;70(3):357-69
Diabetic cardiomyopathy and inflammation: development of hostile microenvironment resulting in cardiac damage
Edoardo ELIA, Stefano MINISTRINI, Federico CARBONE, Fabrizio MONTECUCCO, *

Minerva Cardiology and Angiology 2022 April;70(2):248-57
The revolution of ATTR amyloidosis in cardiology: certainties, gray zones and perspectives
Claudio RAPEZZI *, Giuseppe VERGARO, Michele EMDIN, Gioele FABBRI, Anna CANTONE, Federico SANGUETTOLI, Alberto AIMO